Gladstone in the News
June 19, 2024
Washington Post—Gladstone Senior Investigator Yadong Huang offers commentary on a new study examining the protective power of the rare “Christchurch” gene variant against Alzheimer’s. (Subscription required)
Alzheimer’s Disease
Huang Lab
Gladstone in the News
March 9, 2022
The APQC Blog—Gladstone President Deepak Srivastava, MD, President Emeritus Robert Mahley, MD, PhD, Senior Investigators Melanie Ott, MD, PhD, and Katie Pollard, PhD, explain how they and others at Gladstone create a collaborative research culture and plan to balance safety with the chance encounters that fuel creativity.
Gladstone Experts
COVID-19
Cardiovascular Disease
Data Science and Biotechnology
Virology
Huang Lab
Ott Lab
Pollard Lab
Srivastava Lab
Weinberger Lab
Gladstone in the News
November 16, 2021
BioIT World—Despite decades of research, medical therapies for Alzheimer’s disease have so far proven elusive. Senior Investigator Yadong Huang describes how his innovative approach to drug repurposing has identified a promising candidate drug that is now moving toward clinical trials.
Gladstone Experts
Alzheimer’s Disease
Neurological Disease
Huang Lab